Iovance Biotherapeutics, Inc.
DE ˙ DB ˙ US4622601007
3,42 € ↑0,02 (0,44%)
2026-06-02
AKTIENPREIS
SecurityDE:2LB / Iovance Biotherapeutics, Inc.
InstitutionCaptrust Financial Advisors
Latest Disclosed Ownership55,157 shares
Latest Disclosed Value $ 193,598
Captrust Financial Advisors reports 17.83% increase in ownership of 2LB / Iovance Biotherapeutics, Inc.

On May 14, 2026 - Captrust Financial Advisors filed a 13F-HR form disclosing ownership of 55,157 shares of Iovance Biotherapeutics, Inc. (DE:2LB) valued at $158,218 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 46,812 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 17.83% during the quarter. The current value of the position is $188,637 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 55,157 8,345 17.83 194 51.97 0.0003
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 46,812 5,563 13.49 128 42.70 0.0002
2025-11-19 2025-09-30 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 41,249 17,481 73.55 90 122.50 0.0002
2025-08-15 2025-06-30 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 23,768 645 2.79 41 -48.05 0.0001
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 23,123 -5,615 -19.54 77 -63.68 0.0002
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 28,738 -20,868 -42.07 213 -54.41 0.0006
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 49,606 24,171 95.03 466 129.06 0.0014
2024-08-15 2024-06-30 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 25,435 -24,589 -49.15 204 -72.60 0.0007
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 50,024 14,556 41.04 741 157.29 0.0027
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS INC COM Stock 462260100 35,468 35,468 288 0.0010
2022-11-16 2022-09-30 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 0 -1,474 -100.00 0 -100.00
2022-08-23 2022-06-30 13F/A-1 IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 1,474 -340 -18.74 16 -46.67 0.0001
2022-08-16 2022-06-30 13F IOVANCE BIOTHERAPEUTICS INC COM COM 462260100 1,762 -52 19 0.0001
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 1,814 496 37.63 30 20.00 0.0002
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 1,318 -81 -5.79 25 -26.47 0.0002
2021-11-16 2021-09-30 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 1,399 339 31.98 34 21.43 0.0003
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 1,060 81 8.27 28 -9.68 0.0003
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 979 279 39.86 31 -3.12 0.0003
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 700 0 0.00 32 33.33 0.0004
2020-11-17 2020-09-30 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 700 0 0.00 24 20.00 0.0004
2020-08-14 2020-06-30 13F IOVANCE BIOTHERAPEUTICS INC COM Common Stock 462260100 700 700 20 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.